Meeting
2023 ASCO Annual Meeting
Racial differences in the utilization of MRI-guided biopsy before prostate cancer diagnosis.
Authors
Grace L. Lu-Yao
Division of Population Science, Department of Medical Oncology, Sidney Kimmel Medical College, Sidney Kimmel Cancer Center at Jefferson Health, Philadelphia, PA
Grace L. Lu-Yao , Krupa Gandhi , Nikita Nikita , Amy L Shaver , Swapnil Sharma , Scott W. Keith , Stephen J. Freedland
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Genitourinary Cancer—Prostate, Testicular, and Penile
Track
Genitourinary Cancer—Prostate, Testicular, and Penile
Sub Track
Prostate Cancer–Local-Regional Disease
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 5093)
DOI
10.1200/JCO.2023.41.16_suppl.5093
Abstract #
5093
Poster Bd #
187
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Genitourinary Cancers Symposium
Contemporary diagnosis of very low risk prostate cancer in a multi-centered hospital system.
First Author: Richard Bennett IV
Poster
2023 ASCO Genitourinary Cancers Symposium
Comparison of transperineal and transrectal biopsy approaches to detect clinically significant prostate cancer in patients undergoing MRI fusion prostate biopsy: A lesion level analysis.
First Author: Andrew Wood
Poster
2023 ASCO Genitourinary Cancers Symposium
Is transrectal ultrasound or magnetic resonance imaging better at estimating prostatic volume for patients with prostate cancer?
First Author: Maxwell Sandberg
Poster
2023 ASCO Genitourinary Cancers Symposium
The natural progression of patients with an IsoPSA value and its predictive ability of clinically significant prostate cancer on biopsy.
First Author: Nour Abdallah